Category : Orthopedic Oncology / Orthopaedics
Afami-cel dramatically shrank sarcoma tumors in almost half of patients participating in a clinical trial, led by Memorial Sloan Kettering Cancer Center (MSK) sarcoma specialist and immunotherapy expert Sandra D’Angelo, MD.
Source : MSKCC
On : 31-Jul-2026